|
|
|
|
| |
TAKE THIS POLL |
|
|
- BRIEF: Teva launches generic Lamictal in US: The company lost its appeal in the US to market generic Aciphex. 23 Jul 2008 21:53 GMT
... appeal in the US to market generic Aciphex. Jul. 23--Teva Pharmaceutical Industries Ltd. (Nasdaq: TEVA; TASE: TEVA) had ... version of GlaxoSmithKline's (NYSE; LSE: GSK) Lamictal treatment for partial seizures and the generalized seizures ...
- Eisai Victorious Over Teva and Dr. Reddy's in Aciphex Compound Patent Case 23 Jul 2008 08:06 GMT
... its salts.Rabeprazole is in a class of drugs known as proton pump inhibitors, which suppress ... suppress gastric acid production in the stomach. Aciphex (rabeprazole sodium) is indicated for the treatment of duodenal ulcers, heartburn, and associated disorders, ...
- Teva launches generic Lamictal in US 23 Jul 2008 07:32 GMT
... appeal in the US to market generic Aciphex. ) had mixed news today. The company ... version of GlaxoSmithKline's (NYSE; LSE: GSK) Lamictal treatment for partial seizures and the generalized seizures ... and GlaxoSmithKline settled patent litigation over the drug in February 2005. In a separate development ...
- US Federal Court upholds Aciphex patent 23 Jul 2008 02:51 GMT
... The decision ensures that the patent for Aciphex (rabeprazole sodium 20mg tablets) remains in force ... approval for its generic version of the drug, which now will not receive final approval ... May 2013. Aciphex is used for the treatment of persistent heartburn and other symptoms associated ...
- Eisai Prevails in Aciphex Suit 23 Jul 2008 02:13 GMT
... in a patent infringement case over proposed generic versions of its proton pump inhibitor Aciphex, a treatment for gastroesophageal reflux disease. This article is viewable by subscribers only. To view this ...
- Reddy's loses plea in US on ulcer drug 22 Jul 2008 23:12 GMT
... on Monday ruling that its abbreviated new drug application (ANDA) and that of Israel’s Teva ... on Eisai Co’s patent on acidity-treating drug Aciphex. Dr Reddy’s will not be able to ... in 2008. It is used for the treatment of persistent heartburn and other symptoms associated ...
- Eisai wins appeals court ruling on Aciphex 22 Jul 2008 14:31 GMT
... Eisai wins appeals court ruling on Aciphex India Infoline News Service / Mumbai Jul ... by Dr. Reddy`s Laboratories Ltd. and Teva Pharmaceutical Industries Ltd., which argued that the patent on the drug is invalid and unenforceable Eisai Co., Japan's fourth-largest drugmaker, ...
- U.S. Federal Circuit Court of Appeals Rules Patent for Aciphex Valid and Enforceable 22 Jul 2008 13:17 GMT
... Today's decision ensures that the patent for ACIPHEX remains in force and also directs the U.S. Food and Drug Administration to change the effective date of ... Manager, PriCara. ACIPHEX is used for the treatment of persistent heartburn and other symptoms associated ...
- U.S. Federal Circuit Court of Appeals Fully Upholds Eisai's Favorable Ruling in Aciphex Patent Infringement Lawsuit Against Teva Pharmaceuticals and Dr. Reddy's Laboratories 22 Jul 2008 12:15 GMT
... Eisai filed the infringement actions in November 2003 contesting ... Dr. Reddy's Laboratories' submission of abbreviated new drug applications (ANDAs) to the Food and Drug ... adults, Aciphex(R) 20 mg is indicated for: treatment of daytime and nighttime heartburn and other ...
- US Appeals Court Rules For Japans Eisai In Acid Reflux Drug Aciphex Fight With Teva 22 Jul 2008 09:26 GMT
... Rules For Japans Eisai In Acid Reflux Drug Aciphex Fight With Teva (InvesTrend Via Acquire Media ... Eisai Co. Ltd s patent for Teva Pharmaceutical Industries Ltd s (NASDAQ: TEVA) acid reflux ...
- US Appeals Court Rules For Japan's Eisai In Acid Reflux Drug Aciphex Fight With Teva 22 Jul 2008 09:20 GMT
... Rules For Japan's Eisai In Acid Reflux Drug Aciphex Fight With Teva Jul 22, 2008 (financialwire.net ... Japan-based Eisai Co. Ltd's patent for Teva Pharmaceutical Industries Ltd's (NASDAQ: ) acid reflux drug ...
- U.S. Federal Circuit Court of Appeals Fully Upholds Eisai's Favorable Ruling in Aciphex(R) Patent In 21 Jul 2008 22:48 GMT
... U.S. Federal Circuit Court of Appeals Fully Upholds Eisai's ... Dr. Reddy's Laboratories' submission of abbreviated new drug applications (ANDAs) to the Food and Drug ... adults, Aciphex(R) 20 mg is indicated for: treatment of daytime and nighttime heartburn and other ...
- U.S. Federal Circuit Court of Appeals Rules Patent for ACIPHEX(R) Valid and Enforceable 21 Jul 2008 22:30 GMT
... Today's decision ensures that the patent for ACIPHEX remains in force and also directs the U.S. Food and Drug Administration to change the effective date of ... Manager, PriCara. ACIPHEX is used for the treatment of persistent heartburn and other symptoms associated ...
- U.S. Federal Circuit Court of Appeals Fully Upholds Eisai's Favorable Ruling in Aciphex(R) Patent Infringement Lawsuit A 21 Jul 2008 21:31 GMT
... U.S. Federal Circuit Court of Appeals Fully Upholds Eisai's ... Dr. Reddy's Laboratories' submission of abbreviated new drug applications (ANDAs) to the Food and Drug ... adults, Aciphex(R) 20 mg is indicated for: treatment of daytime and nighttime heartburn and other ...
- U.S. Federal Circuit Court of Appeals Fully Upholds Eisai's Favorable Ruling in Aciphex(R) Patent Infringement Lawsuit Against Teva Pharmaceuticals and Dr. Reddy's Laboratories 21 Jul 2008 21:16 GMT
... U.S. Federal Circuit Court of Appeals Fully Upholds Eisai's ... Dr. Reddy's Laboratories' submission of abbreviated new drug applications (ANDAs) to the Food and Drug ... adults, Aciphex(R) 20 mg is indicated for: treatment of daytime and nighttime heartburn and other ...
- U.S. court rules for Eisai in drug fight with Teva 21 Jul 2008 16:35 GMT
... legal fight on Monday with Israel's Teva Pharmaceutical Industries Ltd (TEVA.O: ), the world's largest ... Ltd (TEVA.O: ), the world's largest generic drug company, over acid reflux drug Aciphex. The U.S. Court of the Appeals for ...
1 - 25 of 49 next >
News by PR Newswire
|
| Tip of the day
Related Newsletters
Come and Visit
|
|
| | |